Generating a Generation of Proteasome Inhibitors: From Microbial Fermentation to Total Synthesis of Salinosporamide A (Marizomib) and Other Salinosporamides
The salinosporamides are potent proteasome inhibitors among which the parent marine-derived natural product salinosporamide A (marizomib; NPI-0052; 1) is currently in clinical trials for the treatment of various cancers. Methods to generate this class of compounds include fermentation and natural pr...
Main Authors: | Barbara C. Potts, Kin S. Lam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-03-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/8/4/835/ |
Similar Items
-
Salinosporamide A, a Marine-Derived Proteasome Inhibitor, Inhibits T Cell Activation through Regulating Proliferation and the Cell Cycle
by: Hyun-Su Lee, et al.
Published: (2020-10-01) -
Vers la synthèse totale de la (-)-salinosporamide A et de la (+)-lactacystine par cycloaddition [2+2] asymétrique
by: Rulliere, Pauline
Published: (2014) -
Biosynthesis and modification of the antibiotic enduracidin
by: Goebel, Neal C.
Published: (2013) -
Chemical synthesis of tripeptide thioesters for the biotechnological incorporation into the myxobacterial secondary metabolite argyrin via mutasynthesis
by: David C. B. Siebert, et al.
Published: (2019-12-01) -
Proteasome inhibitors: situation and prospects (literature review and own data)
by: A. A. Rukavitsyn, et al.
Published: (2016-10-01)